D-1047-2019 Class II Terminated
FDA drug recall D-1047-2019 was initiated by American Health Packaging on Mar 6, 2019 and is designated Class II. Reason for recall: CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient. The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 3337 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2019
- Initiation Date
- Mar 6, 2019
- Termination Date
- Sep 9, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3337 cartons
Product description
Valsartan Tablets USP 160 mg, 100 Tablets (10 x 10) per Unit Dose Blisters, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217 (Individual Dose NDC:60687-139-11, Carton NDC#: 60687-139-01)
Reason for recall
CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot 179791, Mar 2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1047-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026